Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 20, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 174,340 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on February 16, 2007, and was advised to the Company on February 19, 2007.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors—Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop—hold an interest in the shares held within the GSK Trust in the same capacity as other employees. No specific risks, contingencies, or unusual items beyond this standard disclosure are mentioned.
Investor Verification Points
- Verify the total number of shares transferred (174,340) and the date of transfer (February 16, 2007).
- Confirm the specific plan involved: SmithKline Beecham Employee Share Option Plan 1991.
- Review the status of the GSK Trust as a discretionary trust for employee beneficiaries.
- Note the involvement of directors Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop as interested parties in the trust.